MedPath

Comparison of remedial effect of mirtazapin and citalopram on the out- patients with major depression and anxiety symptoms.

Not Applicable
Conditions
Major Depressive Disorder.
Recurrent Depressive Disorder
Registration Number
IRCT2012101811155N1
Lead Sponsor
niversity of Social Welfare and Rehabilitation Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
64
Inclusion Criteria

Diagnosis of Major Depressive Disorder by DSM-IV and anxiety symptoms by Beck Anxiety Rating Scale ( at least 16) and Hamilton Anxiety Rating Scale (at least 13);Age between 18 -65 years old;lack of phisical disorder. Exclusion criteria: History of bipolar disorder or schizoaffective ; Suicide or homicide risk; Contraindication for psychiatric medicine;ECT in the last month;Substance abuse;Pregnancy;Breastfeeding;Planning a pregnancy in female;Psychosis

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Depression. Timepoint: In week 0,2,4,8. Method of measurement: Hamilton and Beck Depression Scale.;Anxiety. Timepoint: in week 0,2,4,8. Method of measurement: hamilton and beck anxiety scale.
Secondary Outcome Measures
NameTimeMethod
Side effect. Timepoint: in week 2,4,8. Method of measurement: check list according to the reference.
© Copyright 2025. All Rights Reserved by MedPath